Direct channel inhibitors |
Lanthanides |
Potent and relatively specific inhibitors (effective at ~ 0.1 –1.0 μM) |
(4, 59) |
2-APB |
Relatively non-specific (effective at ~30 μM) |
(3) |
Analogs of APB (“improved”) |
Improved potency/specificity (effective at ~ 0.6 6.6 μM) |
(79) |
|
Mechanism-based inhibitors |
Nocodazole |
Microtubule disrupter ~ 10 μM; however, inhibition is incomplete |
(60) |
ML-9 |
Inhibits STIM translocation, not through MLCK inhibition; (~10 μM) |
(64) |
2-APB |
Weakly inhibits STIM translocation (~ 10 100 μM) |
(48) |
|
Mechanism not known |
BTPs |
Also activate TRPM4 |
(83, 103) |
Synta66 |
|
(102) |
Other recently described small molecules |
|
[See (92)]
|
Relatively non-specific inhibitors |
|
[See (3)]
|